(Q34583547)

3 August 2017

1 reference

title

Indolocarbazole natural products: occurrence, biosynthesis, and biological activity (English)

1 reference

3 August 2017

1 reference

César Sánchez

1

0 references

Carmen Méndez

object named as

Carmen Méndez

series ordinal

2

0 references

author name string

José A Salas

series ordinal

3

1 reference

3 August 2017

publication date

19 October 2006

1 reference

3 August 2017

published in

Natural Product Reports

1 reference

3 August 2017

volume

23

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

1007-1045

1 reference

Rebeccamycin analogues as anti-cancer agents

3 August 2017

cites work

1 reference

Isolation and synthesis of biologically active carbazole alkaloids

21 January 2018

1 reference

Engineering biosynthetic pathways to generate antitumor indolocarbazole derivatives

21 January 2018

1 reference

Characterization of the biosynthetic gene cluster of rebeccamycin from Lechevalieria aerocolonigenes ATCC 39243.

21 January 2018

1 reference

Use of red-shifted dyes in a fluorescence polarization AKT kinase assay for detection of biological activity in natural product extracts

21 January 2018

1 reference

Drug discovery from natural products

21 January 2018

1 reference

Isolation of bisindole alkaloids that inhibit the cell cycle from Myxomycetes Arcyria ferruginea and Tubifera casparyi.

21 January 2018

1 reference

New bisindole alkaloids isolated from Myxomycetes Arcyria cinerea and Lycogala epidendrum

21 January 2018

1 reference

Ambigol C and 2,4-dichlorobenzoic acid, natural products produced by the terrestrial cyanobacterium Fischerella ambigua

21 January 2018

1 reference

Staurosporine aglycone (K252-c) and arcyriaflavin A from the marine ascidian, Eudistoma sp.

21 January 2018

1 reference

Further new staurosporine derivatives from the ascidian Eudistoma toealensis and its predatory flatworm Pseudoceros sp.

21 January 2018

1 reference

Unusual sulfamate indoles and a novel indolo[3,2-a]carbazole from Ancorina sp.

21 January 2018

1 reference

Chromobacterium violaceum: a review of pharmacological and industiral perspectives

21 January 2018

1 reference

The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability

21 January 2018

1 reference

Pityrialactone- a new fluorochrome from the tryptophan metabolism of Malassezia furfur

21 January 2018

1 reference

Pityriarubins, novel highly selective inhibitors of respiratory burst from cultures of the yeast Malassezia furfur: comparison with the bisindolylmaleimide arcyriarubin A.

21 January 2018

1 reference

Absolute Configuration of Staurosporine By X-Ray Analysis

21 January 2018

1 reference

Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase

21 January 2018

1 reference

Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases

21 January 2018

1 reference

K-252a, a potent protein kinase inhibitor, blocks nerve growth factor-induced neurite outgrowth and changes in the phosphorylation of proteins in PC12h cells

21 January 2018

1 reference

Anti-proliferative effects of new staurosporine derivatives isolated from a marine ascidian and its predatory flatworm

21 January 2018

1 reference

Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin

21 January 2018

1 reference

Biosynthesis of violacein: intact incorporation of the tryptophan molecule on the oxindole side, with intramolecular rearrangement of the indole ring on the 5-hydroxyindole side

21 January 2018

1 reference

The biosynthetic gene cluster for the antitumor rebeccamycin: characterization and generation of indolocarbazole derivatives

21 January 2018

1 reference

The biosynthesis of indolocarbazoles in a heterologous E. coli host.

21 January 2018

1 reference

Molecular analysis of the rebeccamycin L-amino acid oxidase from Lechevalieria aerocolonigenes ATCC 39243

21 January 2018

1 reference

Combinatorial biosynthesis of antitumor indolocarbazole compounds

21 January 2018

1 reference

Deciphering indolocarbazole and enediyne aminodideoxypentose biosynthesis through comparative genomics: insights from the AT2433 biosynthetic locus.

21 January 2018

1 reference

Deciphering the late steps in the biosynthesis of the anti-tumour indolocarbazole staurosporine: sugar donor substrate flexibility of the StaG glycosyltransferase

21 January 2018

1 reference

Cloning and heterologous expression of a natural product biosynthetic gene cluster from eDNA.

21 January 2018

1 reference

Reevaluation of the violacein biosynthetic pathway and its relationship to indolocarbazole biosynthesis.

21 January 2018

1 reference

Enzymatic generation of the chromopyrrolic acid scaffold of rebeccamycin by the tandem action of RebO and RebD.

21 January 2018

1 reference

Robust in vitro activity of RebF and RebH, a two-component reductase/halogenase, generating 7-chlorotryptophan during rebeccamycin biosynthesis

21 January 2018

1 reference

Enzymatic assembly of the bis-indole core of rebeccamycin

21 January 2018

1 reference

RebG- and RebM-catalyzed indolocarbazole diversification

21 January 2018

1 reference

Natural product diversification using a non-natural cofactor analogue of S-adenosyl-L-methionine.

21 January 2018

1 reference

Cytochrome P450 homolog is responsible for C-N bond formation between aglycone and deoxysugar in the staurosporine biosynthesis of Streptomyces sp. TP-A0274.

21 January 2018

1 reference

DNA binding and topoisomerase I poisoning activities of novel disaccharide indolocarbazoles

21 January 2018

1 reference

Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells

21 January 2018

1 reference

(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta

21 January 2018

1 reference

Synthesis and biological evaluation of novel bisindolylmaleimides that inhibit vascular endothelial cell proliferation

21 January 2018

1 reference

Synthesis and cytotoxic activity of different open indolocarbazole alkaloid analogues.

21 January 2018

1 reference

Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCβ

21 January 2018

1 reference

Syntheses and biological activities of rebeccamycin analogues with uncommon sugars

21 January 2018

1 reference

Semi-synthesis, topoisomerase I and kinases inhibitory properties, and antiproliferative activities of new rebeccamycin derivatives.

21 January 2018

1 reference

Cytotoxicities of three rebeccamycin derivatives in the National Cancer Institute screening of 60 human tumor cell lines.

21 January 2018

1 reference

Topoisomerase I inhibitors: selectivity and cellular resistance.

21 January 2018

1 reference

Alterations in receptor expression or agonist concentration change the pathways gastrin-releasing peptide receptor uses to regulate extracellular signal-regulated kinase

21 January 2018

1 reference

Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties

21 January 2018

1 reference

Synthesis and biological activities of indolocarbazoles bearing amino acid residues

21 January 2018

1 reference

Rebeccamycin analogues bearing amine substituents or other groups on the sugar moiety

21 January 2018

1 reference

Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro

21 January 2018

1 reference

Syntheses and biological activities of rebeccamycin analogues. Introduction of a halogenoacetyl substituent

21 January 2018

1 reference

Synthesis, mode of action, and biological activities of rebeccamycin bromo derivatives

21 January 2018

1 reference

Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase

21 January 2018

1 reference

Synthesis of N-alkyl substituted indolocarbazoles as potent inhibitors of human cytomegalovirus replication

21 January 2018

1 reference

Effects of maribavir and selected indolocarbazoles on Epstein-Barr virus protein kinase BGLF4 and on viral lytic replication

21 January 2018

1 reference

The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells.

21 January 2018

1 reference

Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity

21 January 2018

1 reference

Ah receptor signaling pathways

21 January 2018

1 reference

Protein phosphorylation in signaling--50 years and counting

21 January 2018

1 reference

Systematic analysis of human kinase genes: a large number of genes and alternative splicing events result in functional and structural diversity

21 January 2018

1 reference

Protein kinases--the major drug targets of the twenty-first century?

21 January 2018

1 reference

The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1beta (Rsk-2) and p70 S6 kinase.

21 January 2018

1 reference

Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X).

21 January 2018

1 reference

Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors

21 January 2018

1 reference

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2

21 January 2018

1 reference

Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential

21 January 2018

1 reference

Structures of staurosporine bound to CDK2 and cAPK--new tools for structure-based design of protein kinase inhibitors

21 January 2018

1 reference

Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine

21 January 2018

1 reference

Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors

21 January 2018

1 reference

Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine

21 January 2018

1 reference

Structural basis for Chk1 inhibition by UCN-01

21 January 2018

1 reference

Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition

21 January 2018

1 reference

Crystallization and preliminary X-ray analysis of two inhibitor complexes of the catalytic domain of death-associated protein kinase

21 January 2018

1 reference

The three-dimensional structure of the ZAP-70 kinase domain in complex with staurosporine: implications for the design of selective inhibitors.

21 January 2018

1 reference

Catalytic domain crystal structure of protein kinase C-theta (PKCtheta).

21 January 2018

1 reference

Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002.

21 January 2018

1 reference

Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.

21 January 2018

1 reference

Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a

21 January 2018

1 reference

Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog

21 January 2018

1 reference

Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors

21 January 2018

1 reference

The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase A.

21 January 2018

1 reference

Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase

21 January 2018

1 reference

Protein kinase inhibitors: insights into drug design from structure.

21 January 2018

1 reference

Synthesis, modeling, and in vitro activity of (3'S)-epi-K-252a analogues. Elucidating the stereochemical requirements of the 3'-sugar alcohol on trkA tyrosine kinase activity

21 January 2018

1 reference

Novel indolylindazolylmaleimides as inhibitors of protein kinase C-beta: synthesis, biological activity, and cardiovascular safety.

21 January 2018

1 reference

Studies on cyclin-dependent kinase inhibitors: indolo-[2,3- a ]pyrrolo[3,4- c ]carbazoles versus bis-indolylmaleimides

21 January 2018

1 reference

Synthesis of 1,7-annulated indoles and their applications in the studies of cyclin dependent kinase inhibitors

21 January 2018

1 reference

Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors

21 January 2018

1 reference

A new class of potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: structure-activity relationships for a series of 9-alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-a]pyrrolo[3,4-c]carbazole-5-ones and the identification of C

21 January 2018

1 reference

Mixed lineage kinase activity of indolocarbazole analogues.

21 January 2018

1 reference

DNA topoisomerases: structure, function, and mechanism

21 January 2018

1 reference

Diversity of DNA topoisomerases I and inhibitors

21 January 2018

1 reference

Siderophores of the human pathogenic fluorescent pseudomonads

21 January 2018

1 reference

Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy

21 January 2018

1 reference

Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents

21 January 2018

1 reference

Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11.

21 January 2018

1 reference

Cellular uptake and interaction with purified membranes of rebeccamycin derivatives.

21 January 2018

1 reference

Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle

21 January 2018

1 reference

Syntheses, biochemical and biological evaluation of staurosporine analogues from the microbial metabolite rebeccamycin

21 January 2018

1 reference

DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin

21 January 2018

1 reference

Formaldehyde-induced alkylation of a 2'-aminoglucose rebeccamycin derivative to both A.T and G.C base pairs in DNA.

21 January 2018

1 reference

Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition.

21 January 2018

1 reference

Conformational Control in the Rebeccamycin Class of Indolocarbazole Glycosides.

21 January 2018

1 reference

Indolocarbazole glycosides in inactive conformations

21 January 2018

1 reference

Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex

21 January 2018

1 reference

A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex

21 January 2018

1 reference

Impact of violacein-producing bacteria on survival and feeding of bacterivorous nanoflagellates

21 January 2018

1 reference

Natural products to drugs: natural product derived compounds in clinical trials

21 January 2018

1 reference

The cell cycle as a target for cancer therapy: basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01.

21 January 2018

1 reference

Review of UCN-01 development: a lesson in the importance of clinical pharmacology

21 January 2018

1 reference

Indifferently pursued or unowned drugs: who should lead where companies do not tread?

21 January 2018

1 reference

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

21 January 2018

1 reference

A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C.

21 January 2018

1 reference

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.

21 January 2018

1 reference

Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412.

21 January 2018

1 reference

CEP-751 inhibits TRK receptor tyrosine kinase activity in vitro exhibits anti-tumor activity

21 January 2018

1 reference

Activity of irinotecan and the tyrosine kinase inhibitor CEP-751 in medullary thyroid cancer

21 January 2018

1 reference

Combinations of the FLT3 inhibitor CEP-701 and chemotherapy synergistically kill infant and childhood MLL-rearranged ALL cells in a sequence-dependent manner

21 January 2018

1 reference

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

21 January 2018

1 reference

Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors

21 January 2018

1 reference

Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications

21 January 2018

1 reference

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial

21 January 2018

1 reference

Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients

21 January 2018

1 reference

The evolution of cancer research and drug discovery at Lilly Research Laboratories

21 January 2018

1 reference

The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway

21 January 2018

1 reference

Plasma stability of two glycosyl indolocarbazole antitumor agents.

21 January 2018

1 reference

Staurosporine and rebeccamycin aglycones are assembled by the oxidative action of StaP, StaC, and RebC on chromopyrrolic acid

21 January 2018

1 reference

Flavin redox chemistry precedes substrate chlorination during the reaction of the flavin-dependent halogenase RebH.

21 January 2018

1 reference

Slime moulds (Myxomycetes) as a source of new biologically active metabolites

21 January 2018

1 reference

20 August 2023

https://opencitations.net/index/coci/api/v1/citations/10.1351/PAC198961030281

Indole Pigments from the Fruiting Bodies of the Slime MoldArcyria denudata

1 reference

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/ANIE.198004591

Pilzpigmente, 41. Naphthochinon-Farbstoffe aus den Schleimpilzen Trichia floriformis und Metatrichia vesparium (Myxomycetes)

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/JLAC.198219820913

New Tryptophan Metabolites from Cultures of the Lipophilic YeastMalassezia furfur

9 March 2024

1 reference

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/HLCA.200590118

Indocarbazostatins C and D, new inhibitors of NGF-induced neuronal differentiation in PC12 cells

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.57.627

Indocarbazostatin and indocarbazostatin B, novel inhibitors of NGF-induced neuronal differentiation in PC12 cells. I. Screening, taxonomy, fermentation and biological activities.

12 April 2024

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.55.355

Cloning of the staurosporine biosynthetic gene cluster from Streptomyces sp. TP-A0274 and its heterologous expression in Streptomyces lividans.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.55.1063

3'-Demethoxy-3'-hydroxystaurosporine-O-methyltransferase from Streptomyces longisporoflavus catalyzing the last step in the biosynthesis of staurosporine

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.51.679

Production, isolation and structure determination of novel fluoroindolocarbazoles from Saccharothrix aerocolonigenes ATCC 39243.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.54.1

4'-N-methyl-5'-hydroxystaurosporine and 5'-hydroxystaurosporine, new indolocarbazole alkaloids from a marine Micromonospora sp. strain

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.53.895

Further minor metabolites of staurosporine produced by a Streptomyces longisporoflavus strain

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.49.519

Production of the staurosporine aglycon K-252c with a blocked mutant of the staurosporine producer strain Streptomyces longisporoflavus and by biotransformation of staurosporine with Streptomyces mediocidicus ATCC 13279

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.48.428

A nitro analogue of staurosporine and other minor metabolites produced by a Streptomyces longisporoflavus strain

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.48.143

Indocarbazostatin, a novel inhibitor of NGF-induced neurite outgrowth from rat pheochromocytoma PC12 cells

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.52.921

A new inhibitor of protein kinase C, RK-1409 (7-oxostaurosporine). II. Fermentation, isolation, physico-chemical properties and structure.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.45.195

A new inhibitor of protein kinase C, RK-1409 (7-oxostaurosporine). I. Taxonomy and biological activity

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.45.189

A new inhibitor of protein kinase C, RK-1409B (4'-demethylamino-4'-hydroxy-3'-epistaurosporine).

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.45.1428

MLR-52, (4'-demethylamino-4',5'-dihydroxystaurosporine), a new inhibitor of protein kinase C with immunosuppressive activity

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.47.281

The staurosporine producing strain Streptomyces longisporoflavus produces metabolites related to K-252a. Proposal for biosynthetic intermediates of K-252a

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.49.1060

Isolation of a bromo analog of rebeccamycin from Saccharothrix aerocolonigenes

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.44.934

A new inhibitor of protein kinase C, RK-286C (4'-demethylamino-4'-hydroxystaurosporine). II. Isolation, physico-chemical properties and structure

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.43.168

A new inhibitor of protein kinase C, RK-286C (4'-demethylamino-4'-hydroxystaurosporine). I. Screening, taxonomy, fermentation and biological activity.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.43.163

Cytotoxic, antiviral indolocarbazoles from a blue-green alga belonging to the Nostocaceae

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.43.1236

A new antibiotic SF-2370 produced by Actinomadura.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.38.1437

A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.30.275

UCN-01 and UCN-02, new selective inhibitors of protein kinase C. II. Purification, physico-chemical properties, structural determination and biological activities

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.571

AT2433-A1, AT2433-A2, AT2433-B1 and AT2433-B2 novel antitumor compounds produced by Actinomadura melliaura. II. Structure determination

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.1784

TAN-999 and TAN-1030A, new indolocarbazole alkaloids with macrophage-activating properties.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.1619

Production and biological activity of rebeccamycin, a novel antitumor agent.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.40.668

AT2433-A1, AT2433-A2, AT2433-B1, and AT2433-B2 novel antitumor antibiotic compounds produced by Actinomadura melliaura. Taxonomy, fermentation, isolation and biological properties.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.1547

UCN-01, a selective inhibitor of protein kinase C from Streptomyces.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.40.1782

The structures of the novel protein kinase C inhibitors K-252a, b, c and d

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.39.1072

K-252a, a potent inhibitor of protein kinase C from microbial origin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.39.1059

Pseudodeoxyviolacein, a New Red Pigment Produced by the Tryptophan Metabolism ofChromobacterium violaceum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB.58.279

A New Metabolite of Tryptophan, Chromopyrrolic Acid, Produced byChromobacterium violaceum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB.57.775

Identifiers

DOI

10.1039/B601930G

1 reference

3 August 2017

1 reference